Literature DB >> 7482

Influence of a meal on the absorption of cimetidine. A new histamine H2-receptor antagonist.

R W Spence, D R Creak, L R Celestin.   

Abstract

Absorption of an oral dose of 300 mg of Cimetidine was studied after an overnight fast in six healthy male volunteers on three separate occasions, 20 min before, during, and 2 h after a standard breakfast. Compared to the doses taken before and after the meal, the dose taken with the meal showed a significant delay in the time taken to reach therapeutic blood concentrations of the drug with no reduction in the period of time during which this concentration was maintained. We, therefore, suggest that the drug should be taken with a meal to achieve optimal acid inhibition in the interdigestive period.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 7482     DOI: 10.1159/000197917

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  7 in total

1.  Bioavailability and pharmacokinetics of cimetidine.

Authors:  A Grahnén; C von Bahr; B Lindström; A Rosén
Journal:  Eur J Clin Pharmacol       Date:  1979-11       Impact factor: 2.953

2.  The absorption of cimetidine before and during maintenance treatment with cimetidine and the influence of a meal on the absorption of cimetidine--studies in patients with peptic ulcer disease.

Authors:  G Bodemar; B Norlander; L Fransson; A Walan
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

3.  Clinical assessment of antisecretory drugs in man.

Authors:  E J Boyd; K G Wormsley
Journal:  Br J Clin Pharmacol       Date:  1982-07       Impact factor: 4.335

4.  The effect of metoclopramide and propantheline on the gastrointestinal absorption of cimetidine.

Authors:  J Kanto; H Allonen; H Jalonen; R Mäntylä
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

5.  Effect of metiamide on basal and stimulated serum cholecystokinin levels in duodenal ulcer patients.

Authors:  R W Spence; L R Celestin; R F Harvey
Journal:  Gut       Date:  1976-11       Impact factor: 23.059

Review 6.  Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.

Authors:  J G Hatlebakk; A Berstad
Journal:  Clin Pharmacokinet       Date:  1996-11       Impact factor: 6.447

Review 7.  Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-02       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.